secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALX ONCOLOGY HOLDINGS INC (ALXO)
CIK:        0001810182
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0000950170-25-058687
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ALX Oncology receives Nasdaq bid price non-compliance notice; 180-day cure until Oct 20, 2025
--------------------------------------------------------------------------------

- Nasdaq notified ALXO on Apr 23, 2025 that its common stock failed to maintain $1.00 minimum bid price for 30 consecutive business days.
- Company has until Oct 20, 2025 to regain compliance by closing at or above $1.00 for at least ten consecutive business days.
- If not cured, ALXO may seek a second 180-day period by transferring to the Nasdaq Capital Market, subject to eligibility.
- Potential cure actions include a reverse stock split; failure to regain compliance could lead to delisting.
- ALXO intends to actively monitor bid price and assess options, but no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810182/000095017025058687/0000950170-25-058687-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810182/000095017025058687/alxo-20250423.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-058687

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer